Litcius/Paper detail

Therapy of asthenia in patients after acute novel coronavirus infection (COVID-19): results of a multicenter, randomized, double-blind, placebocontrolled clinical study

Ostroumova O.D. Ostroumova, Ebzeeva E.Yu. Ebzeeva, Polyakova O.A. Polyakova, Gantseva Kh.Kh. Gantseva, Malchikova S.V. Malchikova, Ershov O.B. Ershov, Kamchatnov P.R. Kamchatnov, Avdeeva M.G. Avdeeva, Filippov E.V. Filippov, Ushakova S.E. Ushakova, Khamitov R.F. Khamitov, Beloglazov V.A. Beloglazov, Pyankov A.F. Pyankov, Grigorovich M.S. Grigorovich, Ezhov A.V. Ezhov

2022Therapy14 citationsDOI

Topics & Concepts

Coronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusRandomized controlled trialVirologyPediatricsInternal medicineDiseaseOutbreakInfectious disease (medical specialty)Intensive Care Unit Cognitive DisordersAnesthesia and Neurotoxicity ResearchLong-Term Effects of COVID-19
Therapy of asthenia in patients after acute novel coronavirus infection (COVID-19): results of a multicenter, randomized, double-blind, placebocontrolled clinical study | Litcius